$ABBV
AbbVie Inc.

2013 Q4 Form 10-K Financial Statement

#000104746914001154 Filed on February 21, 2014

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2013 Q2
Revenue $5.111B $4.658B $4.692B
YoY Change -1.82% 3.33% 4.43%
Cost Of Revenue $1.286B $1.092B $1.054B
YoY Change 1.66% 7.69% -1.77%
Gross Profit $3.829B $3.566B $3.638B
YoY Change -2.84% 2.06% 6.37%
Gross Profit Margin 74.92% 76.56% 77.54%
Selling, General & Admin $1.448B $1.261B $1.406B
YoY Change 2.62% 16.22% 12.84%
% of Gross Profit 37.82% 35.36% 38.65%
Research & Development $783.0M $714.0M $709.0M
YoY Change 57.23% -12.18% 10.44%
% of Gross Profit 20.45% 20.02% 19.49%
Depreciation & Amortization $200.0M $97.00M $100.0M
YoY Change -35.28% 4.3% -15.97%
% of Gross Profit 5.22% 2.72% 2.75%
Operating Expenses $2.231B $1.975B $2.115B
YoY Change 16.87% 4.06% 12.02%
Operating Profit $1.598B $1.371B $1.453B
YoY Change -21.36% -14.1% 2.18%
Interest Expense -$79.00M $75.00M $79.00M
YoY Change 1.28% 650.0% 3850.0%
% of Operating Profit -4.94% 5.47% 5.44%
Other Income/Expense, Net -$13.00M -$5.000M $4.000M
YoY Change -56.67% -138.46% -136.36%
Pretax Income $1.439B $1.286B $1.368B
YoY Change -16.0% -19.83% -2.43%
Income Tax $311.0M $322.0M $300.0M
% Of Pretax Income 21.61% 25.04% 21.93%
Net Earnings $1.128B $964.0M $1.068B
YoY Change -26.75% -39.18% -15.71%
Net Earnings / Revenue 22.07% 20.7% 22.76%
Basic Earnings Per Share $0.70 $0.60 $0.67
Diluted Earnings Per Share $0.70 $0.60 $0.66
COMMON SHARES
Basic Shares Outstanding 1.590B shares 1.589B shares
Diluted Shares Outstanding 1.605B shares 1.609B shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.895B $9.596B $8.754B
YoY Change 24.06% 109.25% 11572.0%
Cash & Equivalents $9.595B $8.975B $8.743B
Short-Term Investments $300.0M $621.0M $11.00M
Other Short-Term Assets $2.000B $1.977B $2.068B
YoY Change 0.55% -13.63% 0.29%
Inventory $1.150B $1.172B $1.085B
Prepaid Expenses
Receivables $3.854B $3.798B $3.755B
Other Receivables $949.0M $0.00 $0.00
Total Short-Term Assets $17.85B $16.54B $15.66B
YoY Change 16.24% 51.34% 161.34%
LONG-TERM ASSETS
Property, Plant & Equipment $2.298B $2.244B $2.213B
YoY Change 2.27% 4.91% 5.78%
Goodwill $6.277B $6.199B $6.120B
YoY Change 2.4%
Intangibles $1.890B $1.993B $2.101B
YoY Change -18.64%
Long-Term Investments $118.0M $123.0M $121.0M
YoY Change -0.84% -39.41% -48.95%
Other Assets $767.0M $1.150B $1.693B
YoY Change -8.14% 23.13% 93.71%
Total Long-Term Assets $11.35B $11.71B $12.25B
YoY Change -2.61% -0.76% 4.53%
TOTAL ASSETS
Total Short-Term Assets $17.85B $16.54B $15.66B
Total Long-Term Assets $11.35B $11.71B $12.25B
Total Assets $29.20B $28.25B $27.91B
YoY Change 8.11% 24.29% 57.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $933.0M $6.441B $6.332B
YoY Change 67.81% 1419.1% 1778.93%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $413.0M $411.0M $410.0M
YoY Change -59.51%
Long-Term Debt Due $18.00M $23.00M $22.00M
YoY Change -18.18%
Total Short-Term Liabilities $6.879B $6.875B $6.805B
YoY Change 1.52% 28.07% 40.6%
LONG-TERM LIABILITIES
Long-Term Debt $14.29B $14.38B $14.33B
YoY Change -2.31%
Other Long-Term Liabilities $1.337B $3.425B $3.221B
YoY Change 48.56% 102.3% 135.97%
Total Long-Term Liabilities $1.337B $17.80B $17.55B
YoY Change 48.56% 951.39% 1185.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.879B $6.875B $6.805B
Total Long-Term Liabilities $1.337B $17.80B $17.55B
Total Liabilities $8.216B $24.68B $24.35B
YoY Change 7.03% 249.45% 292.52%
SHAREHOLDERS EQUITY
Retained Earnings $1.567B $1.081B $758.0M
YoY Change
Common Stock $3.671B $3.580B $4.074B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $320.0M $119.0M $121.0M
YoY Change
Treasury Stock Shares 6.900M shares 3.100M shares 3.131M shares
Shareholders Equity $4.492B $3.577B $3.558B
YoY Change
Total Liabilities & Shareholders Equity $29.20B $28.25B $27.91B
YoY Change 8.11% 24.29% 57.59%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2013 Q2
OPERATING ACTIVITIES
Net Income $1.128B $964.0M $1.068B
YoY Change -26.75% -39.18% -15.71%
Depreciation, Depletion And Amortization $200.0M $97.00M $100.0M
YoY Change -35.28% 4.3% -15.97%
Cash From Operating Activities $1.245B $1.798B $2.037B
YoY Change 32.17% -20.02% 30.49%
INVESTING ACTIVITIES
Capital Expenditures -$151.0M -$133.0M -$119.0M
YoY Change 58.95% -838.89% 26.6%
Acquisitions $134.0M
YoY Change
Other Investing Activities $274.0M -$831.0M $352.0M
YoY Change -346.85% -54.44% -425.93%
Cash From Investing Activities $123.0M -$964.0M $233.0M
YoY Change -159.71% -46.62% -215.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -747.0M -613.0M -500.0M
YoY Change -131.27% -127.32% -62.29%
NET CHANGE
Cash From Operating Activities 1.245B 1.798B 2.037B
Cash From Investing Activities 123.0M -964.0M 233.0M
Cash From Financing Activities -747.0M -613.0M -500.0M
Net Change In Cash 621.0M 221.0M 1.770B
YoY Change -80.13% -91.77% 5263.64%
FREE CASH FLOW
Cash From Operating Activities $1.245B $1.798B $2.037B
Capital Expenditures -$151.0M -$133.0M -$119.0M
Free Cash Flow $1.396B $1.931B $2.156B
YoY Change 34.62% -13.41% 30.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012 us-gaap Sales Revenue Net
SalesRevenueNet
18380000000 USD
CY2011 us-gaap Sales Revenue Net
SalesRevenueNet
17444000000 USD
CY2012 us-gaap Cost Of Goods Sold
CostOfGoodsSold
4508000000 USD
CY2011 us-gaap Cost Of Goods Sold
CostOfGoodsSold
4639000000 USD
CY2012 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4989000000 USD
CY2011 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5894000000 USD
CY2012 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
2778000000 USD
CY2011 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
2618000000 USD
CY2012 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
288000000 USD
CY2011 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
673000000 USD
CY2012 us-gaap Costs And Expenses
CostsAndExpenses
12563000000 USD
CY2011 us-gaap Costs And Expenses
CostsAndExpenses
13824000000 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
5817000000 USD
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
3620000000 USD
CY2012 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-84000000 USD
CY2011 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
20000000 USD
CY2012 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-17000000 USD
CY2011 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
30000000 USD
CY2012 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000000 USD
CY2011 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.18
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1577000000 shares
CY2012 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1577000000 shares
CY2011 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000000 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5725000000 USD
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3668000000 USD
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
450000000 USD
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
235000000 USD
CY2012 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5275000000 USD
CY2011 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3433000000 USD
CY2012 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.35
CY2012 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.35
CY2011 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.18
CY2011 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1577000000 shares
CY2011 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1577000000 shares
CY2013 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.00
CY2013 us-gaap Costs And Expenses
CostsAndExpenses
13126000000 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
5664000000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5332000000 USD
CY2013 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4128000000 USD
CY2013 dei Entity Registrant Name
EntityRegistrantName
AbbVie Inc.
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0001551152
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2012 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
173000000 USD
CY2011 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-295000000 USD
CY2011 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
7000000 USD
CY2011 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
17000000 USD
CY2011 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
-28000000 USD
CY2011 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-313000000 USD
CY2011 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3120000000 USD
CY2012 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
150000000 USD
CY2012 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-25000000 USD
CY2012 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
-27000000 USD
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-29000000 USD
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5246000000 USD
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4698000000 USD
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
570000000 USD
CY2013 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
309000000 USD
CY2012 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
-24000000 USD
CY2011 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
-12000000 USD
CY2013 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
0 USD
CY2012 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
-15000000 USD
CY2011 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
10000000 USD
CY2013 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent
0 USD
CY2012 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent
-8000000 USD
CY2011 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent
-8000000 USD
CY2012Q4 us-gaap Short Term Investments
ShortTermInvestments
2075000000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2247000000 USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5901000000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
1091000000 USD
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
669000000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
1320000000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
15354000000 USD
CY2012Q4 us-gaap Long Term Investments
LongTermInvestments
119000000 USD
CY2012Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
2239000000 USD
CY2013Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
16000000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2323000000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
6130000000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
835000000 USD
CY2012Q4 us-gaap Assets
Assets
27008000000 USD
CY2012Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
1020000000 USD
CY2012Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
22000000 USD
CY2012Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5734000000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6776000000 USD
CY2012Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
14630000000 USD
CY2012Q4 abbv Parent Investment Prior To Separation
ParentInvestmentPriorToSeparation
3713000000 USD
CY2012Q4 abbv Stockholders Equity Including Parent Investment Prior To Separation
StockholdersEquityIncludingParentInvestmentPriorToSeparation
3363000000 USD
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
320000000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3671000000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1567000000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-350000000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-350000000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27008000000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29198000000 USD
CY2013Q4 abbv Stockholders Equity Including Parent Investment Prior To Separation
StockholdersEquityIncludingParentInvestmentPriorToSeparation
4492000000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
4492000000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6879000000 USD
CY2013Q4 us-gaap Assets
Assets
29198000000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
17848000000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1594260996 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
6900434 shares
CY2012 us-gaap Depreciation
Depreciation
525000000 USD
CY2011 us-gaap Depreciation
Depreciation
508000000 USD
CY2012 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
625000000 USD
CY2011 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
764000000 USD
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
187000000 USD
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
163000000 USD
CY2012 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-66000000 USD
CY2012 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-223000000 USD
CY2011 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
498000000 USD
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
203000000 USD
CY2011 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
87000000 USD
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-90000000 USD
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
206000000 USD
CY2012 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-731000000 USD
CY2011 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1497000000 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
6345000000 USD
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
347000000 USD
CY2011 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
6247000000 USD
CY2012 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
688000000 USD
CY2011 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
273000000 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
333000000 USD
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
356000000 USD
CY2011 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-1870000000 USD
CY2012 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2550000000 USD
CY2011 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1943000000 USD
CY2012 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1153000000 USD
CY2011 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1255000000 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2418000000 USD
CY2011 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
553000000 USD
CY2012 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
1000000000 USD
CY2012 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-13504000000 USD
CY2012 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-151000000 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1931000000 USD
CY2011 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-6762000000 USD
CY2011 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-21000000 USD
CY2011 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-6783000000 USD
CY2012 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
16000000 USD
CY2012 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
5874000000 USD
CY2011 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
17000000 USD
CY2013 us-gaap Payments Of Dividends
PaymentsOfDividends
2555000000 USD
CY2013 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
320000000 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-3442000000 USD
CY2013 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
3694000000 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
879000000 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
6267000000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10000000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27000000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9595000000 USD
CY2013Q2 dei Entity Public Float
EntityPublicFloat
64886944938 USD
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1588518764 shares
CY2010Q4 abbv Stockholders Equity Including Parent Investment Prior To Separation
StockholdersEquityIncludingParentInvestmentPriorToSeparation
15703000000 USD
CY2011Q4 abbv Stockholders Equity Including Parent Investment Prior To Separation
StockholdersEquityIncludingParentInvestmentPriorToSeparation
11932000000 USD
CY2013 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2561000000 USD
CY2013 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
486000000 USD
CY2011 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
6891000000 USD
CY2012 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
13519000000 USD
CY2013 us-gaap Interest Expense
InterestExpense
299000000 USD
CY2012 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
20000000 USD
CY2013 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-278000000 USD
CY2012 us-gaap Interest Expense
InterestExpense
104000000 USD
CY2012Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
398000000 USD
CY2012Q4 abbv Accrued Sales Rebates
AccruedSalesRebates
1616000000 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1718000000 USD
CY2013Q4 abbv Accrued Sales Rebates
AccruedSalesRebates
1401000000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
933000000 USD
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
621000000 USD
CY2013Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
443000000 USD
CY2013Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
1628000000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1531000000 USD
CY2012Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
979000000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1337000000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
900000000 USD
CY2013 abbv Number Of Principal Us Customers
NumberOfPrincipalUSCustomers
3 customer
CY2013Q1 abbv Common Stock Distribution Ratio
CommonStockDistributionRatio
1 pure
CY2013 abbv Separation Related Expenses
SeparationRelatedExpenses
254000000 USD
CY2011 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
20000000 USD
CY2013 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
21000000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
556000000 USD
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
523000000 USD
CY2012 abbv Separation Related Expenses
SeparationRelatedExpenses
288000000 USD
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="FONT-FAMILY: times;"><font size="2"><b>Use of Estimates</b></font></p> <p style="FONT-FAMILY: times;"><font size="2">The financial statements have been prepared in accordance with U.S.&#160;GAAP and necessarily include amounts based on estimates and assumptions by management. Actual results could differ from those amounts. Significant estimates include amounts for sales rebates, pension and post-employment benefits, income taxes, litigation, valuation of intangible assets and goodwill, financial instruments, and inventory and accounts receivable exposures.</font></p> </div>
CY2013 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="FONT-FAMILY: times;"><font size="2"><b>Product Liability</b></font></p> <p style="FONT-FAMILY: times;"><font size="2">AbbVie accrues for product liability claims, on an undiscounted basis, when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on existing information. The liabilities are adjusted quarterly as additional information becomes available. Receivables for insurance recoveries, if any, for product liability claims are recorded as assets, on an undiscounted basis, when it is probable that a recovery will be realized.</font></p> </div>
CY2012 us-gaap Advertising Expense
AdvertisingExpense
506000000 USD
CY2011 us-gaap Advertising Expense
AdvertisingExpense
375000000 USD
CY2013 us-gaap Advertising Expense
AdvertisingExpense
626000000 USD
CY2013 abbv Amortization Period Of Differences Between Expected Long Term Return On Plan Assets And The Actual Return
AmortizationPeriodOfDifferencesBetweenExpectedLongTermReturnOnPlanAssetsAndTheActualReturn
P5Y
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
83000000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
88000000 USD
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
485000000 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
547000000 USD
CY2013Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
404000000 USD
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
286000000 USD
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
258000000 USD
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
261000000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
1150000000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4295000000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6542000000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6909000000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4611000000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2298000000 USD
CY2013 us-gaap Depreciation
Depreciation
388000000 USD
CY2013 us-gaap Participating Securities Distributed And Undistributed Earnings
ParticipatingSecuritiesDistributedAndUndistributedEarnings
26000000 USD
CY2013 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
405000000 USD
CY2013 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
338000000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
6277000000 USD
CY2013 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
25000000 USD
CY2012 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
30000000 USD
CY2013Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5668000000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5738000000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3765000000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4295000000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1903000000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1443000000 USD
CY2012Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
420000000 USD
CY2013Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
447000000 USD
CY2012Q4 abbv Total Indefinite Lived Intangible Assets Excluding Goodwill
TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill
420000000 USD
CY2013Q4 abbv Total Indefinite Lived Intangible Assets Excluding Goodwill
TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill
447000000 USD
CY2012Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
6088000000 USD
CY2013Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
6185000000 USD
CY2012Q4 abbv Accumulated Amortization Total
AccumulatedAmortizationTotal
3765000000 USD
CY2013Q4 abbv Accumulated Amortization Total
AccumulatedAmortizationTotal
4295000000 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1890000000 USD
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
509000000 USD
CY2012 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
13000000 USD
CY2011 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
46000000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
352000000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
279000000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
137000000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
131000000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
115000000 USD
CY2012Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
14652000000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
87000000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
79000000 USD
CY2013Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
14310000000 USD
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
18000000 USD
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
14292000000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
71000000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
62000000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
46000000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
530000000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
875000000 USD
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months
LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths
18000000 USD
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
4012000000 USD
CY2012Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
15000000 USD
CY2013Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
17000000 USD
CY2012Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
106000000 USD
CY2013Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
505000000 USD
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
11000000 USD
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
4008000000 USD
CY2013 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
71000000 USD
CY2013Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
3854000000 USD
CY2011Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
349000000 USD
CY2012Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
251000000 USD
CY2013Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
165000000 USD
CY2012 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
134000000 USD
CY2013 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
131000000 USD
CY2012 abbv Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Other
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOther
7000000 USD
CY2013Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
28000000 USD
CY2012 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
29000000 USD
CY2013 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
17000000 USD
CY2013Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0 USD
CY2013Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0 USD
CY2013Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0 USD
CY2013Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0 USD
CY2013 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
28000000 USD
CY2012Q4 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
898000000 USD
CY2013Q4 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
3666000000 USD
CY2013 abbv Payments For Repurchase Of Common Stock On Open Market
PaymentsForRepurchaseOfCommonStockOnOpenMarket
223000000 USD
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
212000000 USD
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
187000000 USD
CY2011 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
163000000 USD
CY2013 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
68000000 USD
CY2012 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
56000000 USD
CY2011 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
48000000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-581000000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
5913000000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5332000000 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
625000000 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
5100000000 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5725000000 USD
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
626000000 USD
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
3042000000 USD
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3668000000 USD
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
226000000 USD
CY2013 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
354000000 USD
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
580000000 USD
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
678000000 USD
CY2013 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-54000000 USD
CY2013Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
624000000 USD
CY2012 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
94000000 USD
CY2012 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
252000000 USD
CY2012 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
346000000 USD
CY2012 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
89000000 USD
CY2012 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
15000000 USD
CY2012 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
104000000 USD
CY2011 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
177000000 USD
CY2011 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
390000000 USD
CY2011 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
567000000 USD
CY2011 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-198000000 USD
CY2011 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-134000000 USD
CY2011 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-332000000 USD
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
195000000 USD
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
370000000 USD
CY2011 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
294000000 USD
CY2011 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
15000000 USD
CY2012 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
220000000 USD
CY2011 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
604000000 USD
CY2012 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
50000000 USD
CY2011 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
430000000 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1204000000 USD
CY2012 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.034 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.112 pure
CY2013 abbv Effective Income Tax Rate Reconciliation Excise Tax Credits Foreign
EffectiveIncomeTaxRateReconciliationExciseTaxCreditsForeign
0.019 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.004 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.006 pure
CY2012 abbv Effective Income Tax Rate Reconciliation Nondeductible Litigation Loss Accrual
EffectiveIncomeTaxRateReconciliationNondeductibleLitigationLossAccrual
0.006 pure
CY2011 abbv Effective Income Tax Rate Reconciliation Nondeductible Litigation Loss Accrual
EffectiveIncomeTaxRateReconciliationNondeductibleLitigationLossAccrual
0.129 pure
CY2012 abbv Effective Income Tax Rate Reconciliation Excise Tax Credits Foreign
EffectiveIncomeTaxRateReconciliationExciseTaxCreditsForeign
0.012 pure
CY2011 abbv Effective Income Tax Rate Reconciliation Excise Tax Credits Foreign
EffectiveIncomeTaxRateReconciliationExciseTaxCreditsForeign
0.032 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.003 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.001 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.003 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.020 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
279000000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
252000000 USD
CY2013Q4 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
67000000 USD
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
122000000 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1580000000 USD
CY2013Q4 abbv Deferred Tax Assets Chargebacks And Rebates
DeferredTaxAssetsChargebacksAndRebates
333000000 USD
CY2013Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1114000000 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
423000000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
190000000 USD
CY2013Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
348000000 USD
CY2012Q4 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
87000000 USD
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
274000000 USD
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1544000000 USD
CY2013Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
64000000 USD
CY2012Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
500000000 USD
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1037000000 USD
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
1000000 USD
CY2011 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
149000000 USD
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
247000000 USD
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1140000000 USD
CY2011Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1039000000 USD
CY2010Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1645000000 USD
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.226 pure
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.079 pure
CY2011 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.064 pure
CY2013 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2013 us-gaap Sales Revenue Net
SalesRevenueNet
18790000000 USD
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.60
CY2013Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.80
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
4692000000 USD
CY2013Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
968000000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
3638000000 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1068000000 USD
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
CY2013Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
4658000000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
3566000000 USD
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6448000000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
570000000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
360000000 USD
CY2013Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
3535000000 USD
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1577000000 shares
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
4329000000 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
3176000000 USD
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
964000000 USD
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.60
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.60
CY2013Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2013Q4 us-gaap Sales Revenue Net
SalesRevenueNet
5111000000 USD
CY2013Q4 us-gaap Gross Profit
GrossProfit
3829000000 USD
CY2013Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1128000000 USD
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.70
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
CY2013Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2012Q1 us-gaap Sales Revenue Net
SalesRevenueNet
4173000000 USD
CY2012Q1 us-gaap Gross Profit
GrossProfit
3017000000 USD
CY2012Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
883000000 USD
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2012Q2 us-gaap Sales Revenue Net
SalesRevenueNet
4493000000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
3420000000 USD
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1267000000 USD
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.80
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.80
CY2012Q3 us-gaap Sales Revenue Net
SalesRevenueNet
4508000000 USD
CY2012Q3 us-gaap Gross Profit
GrossProfit
3494000000 USD
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1585000000 USD
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.01
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.01
CY2012Q4 us-gaap Sales Revenue Net
SalesRevenueNet
5206000000 USD
CY2012Q4 us-gaap Gross Profit
GrossProfit
3941000000 USD
CY2012Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1540000000 USD
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.98
CY2012Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.98
CY2011Q4 us-gaap Goodwill
Goodwill
6100000000 USD
CY2013 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
122000000 USD
CY2012Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
4298000000 USD
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000000 shares
CY2012 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-296000000 USD
CY2012 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
36000000 USD
CY2013 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-55000000 USD
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000 USD
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.58
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.56
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1589000000 shares
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1604000000 shares
CY2013 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
48000000 USD
CY2012 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
14586000000 USD
CY2012 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.235 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.254 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.115 pure
CY2013 abbv Unrecognized Tax Benefits Decreases Resulting From Separation Related Adjustments
UnrecognizedTaxBenefitsDecreasesResultingFromSeparationRelatedAdjustments
1088000000 USD
CY2013Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
218000000 USD
CY2013Q4 abbv Reimbursement Receivable For Unrecognized Tax Benefit And Related Interest And Penalties
ReimbursementReceivableForUnrecognizedTaxBenefitAndRelatedInterestAndPenalties
41000000 USD
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal After Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive
5743000000 USD
CY2013 us-gaap Cost Of Goods Sold
CostOfGoodsSold
4581000000 USD
CY2013 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5352000000 USD
CY2013 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
2855000000 USD
CY2013 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-598000000 USD
CY2013 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
1000000 USD
CY2013 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
-77000000 USD
CY2013Q4 us-gaap Short Term Investments
ShortTermInvestments
300000000 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
766000000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
1234000000 USD
CY2013Q4 us-gaap Long Term Investments
LongTermInvestments
118000000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
767000000 USD
CY2013Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
413000000 USD
CY2012 abbv Tax Benefits Recognized Due To Favorable Resolution Of Tax Positions
TaxBenefitsRecognizedDueToFavorableResolutionOfTaxPositions
195000000 USD
CY2011 abbv Tax Benefits Recognized Due To Favorable Resolution Of Tax Positions
TaxBenefitsRecognizedDueToFavorableResolutionOfTaxPositions
410000000 USD
CY2013Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
21000000000 USD
CY2010Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
288000000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25000000 USD
CY2012 abbv Other Comprehensive Income Loss Separation Related Adjustments Net Of Tax
OtherComprehensiveIncomeLossSeparationRelatedAdjustmentsNetOfTax
-296000000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-442000000 USD
CY2013 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
491000000 USD
CY2013 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-79000000 USD
CY2013 abbv Other Comprehensive Income Loss Separation Related Adjustments Net Of Tax
OtherComprehensiveIncomeLossSeparationRelatedAdjustmentsNetOfTax
-1271000000 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
100000000 shares
CY2013Q1 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
1500000000 USD
CY2013 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
4000000 shares
CY2013 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount
1300000000 USD
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013 abbv Number Of Equity Awards Outstanding Prior To Distribution
NumberOfEquityAwardsOutstandingPriorToDistribution
0 shares
CY2013Q4 us-gaap Number Of Credit Risk Derivatives Held
NumberOfCreditRiskDerivativesHeld
0 item
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
212000000 USD
CY2013 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-34000000 USD
CY2013 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-681000000 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
56000000 USD
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-459000000 USD
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-426000000 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
491000000 USD
CY2013 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
930000000 USD
CY2013 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
2705000000 USD
CY2013 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-601000000 USD
CY2013 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-247000000 USD
CY2013 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-66000000 USD
CY2013 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-10000000 USD
CY2013Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
585000000 USD
CY2013 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 USD
CY2013Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
949000000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
-38000000 USD
CY2013 us-gaap Interest Paid Net
InterestPaidNet
283000000 USD
CY2012 us-gaap Interest Paid Net
InterestPaidNet
61000000 USD
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
1305000000 USD
CY2012Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
14700000000 USD
CY2013 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
223000000 USD
CY2012Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
923000000 USD
CY2013Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
876000000 USD
CY2013Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
643000000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
173000000 USD
CY2012Q4 abbv Deferred Tax Assets Chargebacks And Rebates
DeferredTaxAssetsChargebacksAndRebates
403000000 USD
CY2012Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
283000000 USD
CY2012Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
42000000 USD
CY2013Q4 abbv Deferred Tax Assets Operating Loss And Other Tax Credit Carryforwards
DeferredTaxAssetsOperatingLossAndOtherTaxCreditCarryforwards
115000000 USD
CY2012Q4 abbv Deferred Tax Assets Operating Loss And Other Tax Credit Carryforwards
DeferredTaxAssetsOperatingLossAndOtherTaxCreditCarryforwards
92000000 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
43000000 USD
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7000000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1537000000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1537000000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
508000000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
606000000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
500000000 USD
CY2012Q4 abbv Liability For Uncertain Tax Positions Current And Noncurrent
LiabilityForUncertainTaxPositionsCurrentAndNoncurrent
0 USD
CY2011Q4 abbv Liability For Uncertain Tax Positions Current And Noncurrent
LiabilityForUncertainTaxPositionsCurrentAndNoncurrent
0 USD
CY2013 us-gaap Defined Benefit Plan Ultimate Health Care Cost Trend Rate
DefinedBenefitPlanUltimateHealthCareCostTrendRate
0.05 pure
CY2013 us-gaap Defined Benefit Plan Effect Of One Percentage Point Increase On Service And Interest Cost Components
DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents
8000000 USD
CY2013 us-gaap Defined Benefit Plan Effect Of One Percentage Point Decrease On Service And Interest Cost Components1
DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1
-6000000 USD
CY2013 us-gaap Defined Benefit Plan Effect Of One Percentage Point Increase On Accumulated Postretirement Benefit Obligation
DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation
71000000 USD
CY2013 us-gaap Defined Benefit Plan Effect Of One Percentage Point Decrease On Accumulated Postretirement Benefit Obligation1
DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1
-56000000 USD
CY2013Q4 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Estimated Range Of Change Upper Bound
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleEstimatedRangeOfChangeUpperBound
22000000 USD
CY2011 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-300000000 USD
CY2011 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
13000000 USD
CY2012 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-18000000 USD
CY2012 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
11000000 USD
CY2013 abbv Common Stock Dividends Per Share Declared Excluding Dividends Declared From Pre Separation Earnings
CommonStockDividendsPerShareDeclaredExcludingDividendsDeclaredFromPreSeparationEarnings
1.60
CY2012Q4 abbv Long Term Debt And Capital Lease Obligations Fair Value Hedges
LongTermDebtAndCapitalLeaseObligationsFairValueHedges
81000000 USD
CY2013Q4 abbv Long Term Debt And Capital Lease Obligations Fair Value Hedges
LongTermDebtAndCapitalLeaseObligationsFairValueHedges
432000000 USD
CY2013Q4 abbv Long Term Debt And Capital Lease Obligations Debt Instrument Unamortized Discounts
LongTermDebtAndCapitalLeaseObligationsDebtInstrumentUnamortizedDiscounts
56000000 USD
CY2012Q4 abbv Long Term Debt And Capital Lease Obligations Debt Instrument Unamortized Discounts
LongTermDebtAndCapitalLeaseObligationsDebtInstrumentUnamortizedDiscounts
71000000 USD
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
107000000 USD
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
1006000000 USD
CY2013Q4 abbv Long Term Debt And Capital Lease Obligations Gross
LongTermDebtAndCapitalLeaseObligationsGross
14798000000 USD
CY2013Q4 abbv Long Term Debt And Capital Lease Obligations Fair Value Hedges And Debt Instrument Unamortized Discounts
LongTermDebtAndCapitalLeaseObligationsFairValueHedgesAndDebtInstrumentUnamortizedDiscounts
488000000 USD
CY2013Q4 abbv Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
2000000 USD
CY2012Q4 abbv Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
1000000 USD
CY2013Q4 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
2 item
CY2013 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
38000000 USD
CY2013Q4 abbv Prepaid Taxes Reclassification From Current Deferred Income Taxes To Prepaid Expenses And Other
PrepaidTaxesReclassificationFromCurrentDeferredIncomeTaxesToPrepaidExpensesAndOther
777000000 USD
CY2012Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
419000000 USD
CY2013 abbv Other Comprehensive Income Loss Separation Related Adjustments Excluding Parent Company Net Of Tax
OtherComprehensiveIncomeLossSeparationRelatedAdjustmentsExcludingParentCompanyNetOfTax
-662000000 USD
CY2012 abbv Other Comprehensive Income Loss Separation Related Adjustments Excluding Parent Company Net Of Tax
OtherComprehensiveIncomeLossSeparationRelatedAdjustmentsExcludingParentCompanyNetOfTax
-296000000 USD
CY2013Q4 us-gaap Noncurrent Assets
NoncurrentAssets
2300000000 USD
CY2012Q4 us-gaap Noncurrent Assets
NoncurrentAssets
2200000000 USD

Files In Submission

Name View Source Status
0001047469-14-001154-index-headers.html Edgar Link pending
0001047469-14-001154-index.html Edgar Link pending
0001047469-14-001154.txt Edgar Link pending
0001047469-14-001154-xbrl.zip Edgar Link pending
a2217723z10-k.htm Edgar Link pending
a2217723zex-10_7.htm Edgar Link pending
a2217723zex-10_9.htm Edgar Link pending
a2217723zex-12.htm Edgar Link pending
a2217723zex-21.htm Edgar Link pending
a2217723zex-23_1.htm Edgar Link pending
a2217723zex-23_2.htm Edgar Link pending
a2217723zex-31_1.htm Edgar Link pending
a2217723zex-31_2.htm Edgar Link pending
a2217723zex-32_1.htm Edgar Link pending
a2217723zex-32_2.htm Edgar Link pending
abbv-20131231.xml Edgar Link completed
abbv-20131231.xsd Edgar Link pending
abbv-20131231_cal.xml Edgar Link unprocessable
abbv-20131231_def.xml Edgar Link unprocessable
abbv-20131231_lab.xml Edgar Link unprocessable
abbv-20131231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g903371.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending